After changing its name and identity, cannabis and psychedelics provider Melodiol (ASX: ME1) has decided to sell off two of its most prominent business units, Sierra Sage Herbs and Halucenex Life Sciences to US-based Panacea Life Sciences for $7.56 million in cash and shares. Panacea Life Sciences focuses on the production, research, and distribution of
Read More
In Australia, over 200,000 people live with epilepsy, a chronic neurological condition that is often characterised by seizures. Thousands are hospitalised every year for epilepsy, and even with anti-seizure medication, some people continue to experience mild to severe seizures. Between 2018 and 2019, the condition accounted for over $300 million in national health expenditure. Epilepsy
Read More
The budding cannabis market in New Zealand continues to flourish as more Kiwis seek an alternative to standard pharmaceutical drugs. Now, just because trends are shifting doesn’t mean it is easier for patients to gain access to cannabis medication. To open up the world of cannabis therapy, New Zealand’s largest cannabis wholesaler is creating a
Read More
The burgeoning arms of cannabis treatment have made their way to Ireland, with regulators easing restrictions which has increased the amount of qualified retailers. Currently, there is a limited number of cannabis retailers in the Republic of Ireland. Today, Althea Group Holdings (ASX: AGH) has been granted a rare opportunity to enter the Irish cannabis
Read More